Ambu A/S narrowed earnings guidance for the full-year 2022/23. For the year, the company expected organic revenue growth guidance to 6%-8%, previously 5%-8%; EBIT margin before special items: 5-6% (maintained as per 10 July 2023).
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
128.9 DKK | +0.12% | -2.20% | +22.39% |
05-15 | Nordic Shares Moved Upward Wednesday; BioArctic Series B Topped Leaders | DJ |
05-14 | Transcript : Ambu A/S, Q2 2024 Earnings Call, May 14, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.39% | 4.98B | |
-4.77% | 182B | |
+4.10% | 114B | |
-3.85% | 67.76B | |
+5.19% | 51.91B | |
+5.54% | 43.23B | |
+6.07% | 41.07B | |
+23.81% | 32.07B | |
+15.86% | 25B | |
-5.06% | 24.35B |
- Stock Market
- Equities
- AMBU B Stock
- News Ambu A/S
- Ambu A/S Narrows Earnings Guidance for the Full-Year 2022/23